Global Life Sciences Solutions Operations UK Ltd.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
17
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Dec 2 to 23, 2026 · next Dec 2
- 5 fees due Jan 2 to 30, 2027 · next Jan 2
- 2 fees due Feb 6 to 27, 2027 · next Feb 6
- 1 fee due Mar 12, 2027The maintenance fee for Porous membranes with a polymer grafting, methods and uses thereof (US 11,754,563) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 4 fees due Apr 13 to 27, 2027 · next Apr 13
- 1 fee due May 12, 2027The maintenance fee for Method, substrate and device for separating nucleic acids (US 10,472,620) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 3 fees due Jun 10 to 30, 2027 · next Jun 10
- 2 fees due Aug 9 to 16, 2027 · next Aug 9
- 6 fees due Sep 1 to 24, 2027 · next Sep 1
- 1 fee due Oct 21, 2027The maintenance fee for Substrates and methods for collection, stabilization and elution of biomolecules (US 10,625,242) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
- 2 fees due Nov 3 to 10, 2027 · next Nov 3
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,951,379 | Isothermal DNA amplification In force · From the USPTO record | In force | From the USPTO record | |
| US 10,100,292 | Mutant Endonuclease V Enzymes and Applications Thereof In force · Low confidence | In force | Low confidence | |
| US 7,790,410 | Method and apparatus for determining hemocompatibility In force · From the USPTO record | In force | From the USPTO record | |
| US 9,506,847 | Method and system for selective isolation of target biological molecules in a general purpose system In force · From the USPTO record | In force | From the USPTO record | |
| US 8,041,090 | Method of, and apparatus and computer software for, performing image processing In force · From the USPTO record | In force | From the USPTO record | |
| US 8,361,712 | Contamination-free reagents for nucleic acid amplification In force · From the USPTO record | In force | From the USPTO record | |
| US 8,131,052 | Method of processing an image In force · From the USPTO record | In force | From the USPTO record | |
| US 11,268,116 | Endonuclase-assisted isothermal amplification using contamination-free reagents In force · From the USPTO record | In force | From the USPTO record | |
| US 8,202,972 | Isothermal DNA amplification In force · From the USPTO record | In force | From the USPTO record | |
| US 9,254,484 | Methods and systems for processing samples on porous substrates In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 124: 4 patents in force now held by others · 10 lapsed for an unpaid fee · 9 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 2 abandoned